- Home
- LAB vs ETON Comparison
LAB vs ETON Comparison
Compare LAB & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- ETON
- Stock Information
- Founded
- LAB 1999
- ETON 2017
- Country
- LAB United States
- ETON United States
- Employees
- LAB N/A
- ETON N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- LAB Industrials
- ETON Health Care
- Exchange
- LAB Nasdaq
- ETON Nasdaq
- Market Cap
- LAB 451.0M
- ETON 428.5M
- IPO Year
- LAB 2011
- ETON 2018
- Fundamental
- Price
- LAB $0.92
- ETON $19.81
- Analyst Decision
- LAB Buy
- ETON Strong Buy
- Analyst Count
- LAB 2
- ETON 3
- Target Price
- LAB $2.50
- ETON $29.00
- AVG Volume (30 Days)
- LAB 1.4M
- ETON 296.7K
- Earning Date
- LAB 05-06-2025
- ETON 05-13-2025
- Dividend Yield
- LAB N/A
- ETON N/A
- EPS Growth
- LAB N/A
- ETON N/A
- EPS
- LAB N/A
- ETON N/A
- Revenue
- LAB $169,687,000.00
- ETON $48,327,000.00
- Revenue This Year
- LAB N/A
- ETON $98.26
- Revenue Next Year
- LAB $12.18
- ETON $51.64
- P/E Ratio
- LAB N/A
- ETON N/A
- Revenue Growth
- LAB 33.86
- ETON 40.88
- 52 Week Low
- LAB $0.92
- ETON $3.18
- 52 Week High
- LAB $2.68
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- LAB 35.28
- ETON 68.53
- Support Level
- LAB $1.00
- ETON $18.27
- Resistance Level
- LAB $1.09
- ETON $20.70
- Average True Range (ATR)
- LAB 0.09
- ETON 1.40
- MACD
- LAB -0.02
- ETON 0.18
- Stochastic Oscillator
- LAB 0.55
- ETON 66.93
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.